Please login to the form below

Not currently logged in
Email:
Password:

Amgen promotes Esteban Santos

He succeeds Madhavan Balachandran as executive vice president of operations

Amgen Esteban SantosAmgen has appointed Esteban Santos as executive vice president of operations, with effect from 25 July.

In his new role Santos will take on responsibility for Amgen's operations, which encompasses manufacturing, process development, quality, engineering and its global supply chain, from Madhavan Balachandran who retires at the end of the year.

Santos joined the California-based biotech in 2007 as vice president of global engineering, and subsequently held a number of roles with increasing responsibility at the firm.

He currently serves as senior vice president of manufacturing with responsibility for worldwide product supply - a position he has held since 2013.

Prior to joining Amgen, Santos worked at Cordis, a Johnson & Johnson company, as site general manager for its Puerto Rico operations.

He has also held several management positions at General Electric, including its industrial and transportation businesses in Connecticut, Puerto Rico and Pennsylvania.

Robert Bradway, chairman and chief executive officer at Amgen, said: “Esteban is a talented leader with a proven track record.

“I'm confident that Esteban and our operations team will maintain our track record of industry-leading performance in serving 'every patient, every time' as we expand globally, launch new products and introduce our next-generation of biomanufacturing technologies.”

21st June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

Lighting the way
How the UK’s Accelerated Access Review aims to guide medical innovations to their destination...
The Heart of the Matter 9: Context is King
McCann Complete Medical outlines why multichannel communications - anchored in strong clinical data from journal publications - must not only be transparent, they must also provide a clear clinical context...
Cell and gene therapies: on course for commercial success?
...

Infographics